Pharmafile Logo
Pharmafocus logo
Advanced Search

R&D

Showing 15 posts of 146 posts found.

Publishing image

ANGLE’s Parsortix system used in new cancer biology research

June 10, 2025
Medical Communications, Research and Development Angle, Oncology, Parsortix system, R&D, biotech, oncology, scientific journals

ANGLE has announced three new peer-reviewed publications demonstrating the use of its Parsortix circulating tumour cell (CTC) harvesting system in …

News

Moderna expands use of AI-ready R&D platform

May 12, 2025
Business Services, Research and Development, Technical Consultancy AI, Benchling, Corporate, Moderna, R&D, digital transformation

Moderna has expanded its partnership with Benchling, a cloud-based research platform, to support its broader research organisation. Previously used by …

News

Galimedix completes key stage of clinical trial for treatment targeting eye and brain diseases

May 9, 2025
Research and Development Galimedix Therapeutics, Neurology, Opthalmology, R&D, clinical trial, neurodegenerative conditions

Clinical biotech, Galimedix Therapeutics, has announced the completion of a single ascending dose (SAD) part of a phase 1 study …

News

Ipsen’s Iqirvo approved for use in NHS Scotland to treat rare liver disease

April 8, 2025
Research and Development R&D, Rare Diseases, Scottish Medicines Consortium, ipsen, primary biliary cholangitis (PBC)

The Scottish Medicines Consortium (SMC) has accepted the use of Ipsen’s Iqirvo (elafibranor) in NHS Scotland for the treatment of …

News

ELRIG appoints Del Trezise as chair

April 8, 2025
Research and Development ELRIG, Pharmacy, R&D, drug discovery, non-profit organisation, pharma

ELRIG, a non-profit volunteer-led organisation dedicated to the drug discovery community, has appointed Del Trezise as chair of the board. …

Appointment

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024
Research and Development AbbVie, Pharmacy, R&D, facility

AbbVie has announced that it is investing approximately €150m in its second largest research and development (R&D) facility worldwide. The …

News

Evotec and Dewpoint Therapeutics enter strategic partnership

November 7, 2023
Research and Development Dewpoint Therapeutics, Evotec, Oncology, R&D, oncology

Evotec and Dewpoint Therapeutics have announced a strategic R&D collaboration for the advancement of Dewpoint’s oncology pipeline programmes of condensate …

News

BMS shares new research and development  plans at the company’s R&D day

September 15, 2023
Research and Development BMS, Pharmacy, R&D, development, research

Bristol Myers Squibb (BMS) recently held a Research and Development (R&D) Day in New York, US, in order to discuss …

News
shutterstock_138095450

UK industry spend on R&D collaborations grows to £377.3 million

July 2, 2019
Manufacturing and Production, Medical Communications, Research and Development ABPI, R&D, pharma

The Association of the British Pharmaceutical Indusxtry (ABPI) has unveiled new data showed that UK industry investment in R&D collaborations …

News
sobi_offices

Sobi acquire Novimmune in deal worth more than £400 million

June 13, 2019
Business Services, Research and Development R&D, emapalumab, immuno-oncology, immunology, pharma

Swedish rare disease specialist Sobi has agreed to buy Swiss firm Novimmune ion a deal worth more than £400 million. …

News
dietmar_berger

Dr Dietmar Berger returns to big pharma

May 31, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Atara, R&D, Sanofi, oncology, pharma, research

Industry veteran Dr Dietmar Berger has joined Sanofi as the company’s new Global Head of Development. Dr Berger joins the …

Appointment

ICR calls for faster access to innovative cancer drugs

April 25, 2019
Medical Communications, Research and Development, Sales and Marketing Cancer, ICR, R&D, access, cancer drugs, incentives, innovation, oncology, pricing

The Institute of Cancer Research (ICR) has called for faster access to innovative cancer drugs in the UK. The call …

News
gsk_ulverston_plant_impression

GSK to make redundancies at plant in Stevenage

April 17, 2019
Research and Development GSK, GlaxoSmithKline, R&D, redundancies, stevenage

GlaxoSmithKline are set to make redundancies at their site in Stevenage. The move comes as the firm takes “a new …

News
1468995876_rb-centre-for-scientific-excellence

Reckitt Benckiser to unveil £105 R&D site in Hull by end of June

April 11, 2019
Manufacturing and Production Hull, R&D, Reckitt Benckiser, UK, pharma

Reckitt Benckiser (RB) has announced that its £105 million research and development facility in the UK city of Hull – …

News
astrocyte5

Antiepileptics increase the risk of pneumonia in people with Alzheimer’s disease

March 21, 2019
Research and Development Alzheimer's, R&D, adverse events, antiepileptic drugs, epilepsy, pneumonia

Antiepileptic drugs increase the risk of pneumonia in people living with Alzheimer’s disease, according to research from the University of …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026